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through GEF-H1 and RhoA
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ABSTRACT
The actin and intermediate filament cytoskeletons contribute to
numerous cellular processes, including morphogenesis, cytokinesis
and migration. These two cytoskeletal systems associate with each
other, but the underlying mechanisms of this interaction are
incompletely understood. Here, we show that inactivation of
vimentin leads to increased actin stress fiber assembly and
contractility, and consequent elevation of myosin light chain
phosphorylation and stabilization of tropomyosin-4.2 (see Geeves
et al., 2015). The vimentin-knockout phenotypes can be rescued by
re-expression of wild-type vimentin, but not by the non-filamentous
‘unit length form’ vimentin, demonstrating that intact vimentin
intermediate filaments are required to facilitate the effects on the
actin cytoskeleton. Finally, we provide evidence that the effects of
vimentin on stress fibers are mediated by activation of RhoA through
its guanine nucleotide exchange factor GEF-H1 (also known as
ARHGEF2). Vimentin depletion induces phosphorylation of the
microtubule-associated GEF-H1 on Ser886, and thereby promotes
RhoA activity and actin stress fiber assembly. Taken together, these
data reveal a new mechanism by which intermediate filaments
regulate contractile actomyosin bundles, and may explain why
elevated vimentin expression levels correlate with increased
migration and invasion of cancer cells.
KEY WORDS: Vimentin, Intermediate filament, Actin, Stress fiber,
RhoA, GEF-H1
INTRODUCTION
The actin cytoskeleton contributes to diverse cell biological,
developmental, physiological and pathological processes in
multicellular animals. Precisely regulated polymerization of actin
filaments provides a force for generating membrane protrusions
and invaginations during cell morphogenesis, migration and
endocytosis. Actin and myosin II filaments also form contractile
structures, where the force is generated by movement of myosin
motor domains along actin filaments. The most prominent
contractile actomyosin structures in non-muscle cells are stress
fibers. Beyond cell migration and morphogenesis, stress fibers
contribute to adhesion, mechanotransduction, endothelial barrier
integrity and myofibril assembly (Burridge and Wittchen, 2013;
Sanger et al., 2005; Tojkander et al., 2015; Wong et al., 1983; Yi
et al., 2012). Stress fibers can be classified into three categories,
which differ in their protein compositions and assembly
mechanisms. Dorsal stress fibers are non-contractile actin bundles
that are assembled through VASP- and formin-catalyzed actin
filament polymerization at focal adhesions. Transverse arcs are
contractile actomyosin bundles that are generated from the Arp2/3-
and formin-nucleated lamellipodial actin filament network. These
two stress fiber types serve as precursors for ventral stress fibers,
which are mechanosensitive actomyosin bundles that are linked to
focal adhesions at their both ends (Hotulainen and Lappalainen,
2006; Tojkander et al., 2011, 2015; Burnette et al., 2011; Skau et al.,
2015; Tee et al., 2015). In addition to actin and myosin II, stress
fibers are composed of a large array of actin-regulating and
signaling proteins, including the actin filament cross-linking protein
α-actinin and the actin filament-decorating tropomyosin proteins
(Tojkander et al., 2012).
The Rho family small GTPases are central regulators of actin
dynamics and organization in eukaryotic cells. Amongst these,
RhoA in particular has been linked to generation of contractile
actomyosin stress fibers. RhoA drives the assembly of focal
adhesion-bound actomyosin bundles by inhibiting proteins that
promote actin filament disassembly, by activating proteins that
catalyze actin filament assembly at focal adhesions and by
stimulating myosin II contractility through activation of ROCK
kinases that catalyze myosin light chain phosphorylation (Heasman
and Ridley, 2008). RhoA can be activated by Rho-guanine
nucleotide exchange factors (Rho-GEFs), including Ect2, GEF-
H1 (also known as ARHGEF2), MyoGEF (also known as
PLEKHG6) and LARG (also known as ARHGEF12), which
stimulate the GDP-to-GTP exchange in the nucleotide-binding
pocket of RhoA. From these, Ect2 has a well-established role in the
formation of contractile actomyosin structures at mitotic exit
(Matthews et al., 2012), whereas the microtubule-associated GEF-
H1 contributes to cell migration, cytokinesis and vesicular traffic
(Ren et al., 1998; Nalbant et al., 2009; Birkenfeld et al., 2007;
Pathak et al., 2012).
In addition to mechanosensitive interplay with focal adhesions
and the plasma membrane, stress fibers interact with other
cytoskeletal elements; microtubules and intermediate filament
(IFs) (Huber et al., 2015; Jiu et al., 2015). IFs are stable but
resilient cytoskeletal structures that provide structural support for
cells and serve as signaling platforms. Vimentin and keratins are the
major IF proteins in mesenchymal and epithelial cells, respectively
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2015). Vimentin can interact with actin filaments both directly
through its C-terminal tail and indirectly through the plectin
cytoskeletal cross-linking protein (Esue et al., 2006; Svitkina et al.,
1996). Furthermore, IFs display robust interactions with
microtubules in cells (Huber et al., 2015). Importantly, several
studies demonstrated that disruption of the actin cytoskeleton affects
subcellular localization of the IF network in cells (Hollenbeck et al.,
1989; Dupin et al., 2011; Jiu et al., 2015). More precisely, transverse
arcs and ventral stress fibers interact with vimentin IFs through
plectin, and retrograde flow of these contractile actomyosin bundles
transports vimentin filaments from the leading edge towards the
perinuclear region of the cell (Jiu et al., 2015). IFs can reciprocally
affect actin-dependent processes such as cell adhesion and
migration, because vimentin depletion results in impaired cell
migration and pronounced stress fiber-attached focal adhesions
(Bhattacharya et al., 2009; Eckes et al., 1998, 2000; Mendez et al.,
2010). Moreover, keratin-8–keratin-18 displays interplay with Solo
(also known as ARHGEF40), a RhoA-GEF, to control force-
induced RhoA activation and consequent stress fiber assembly
(Fujiwara et al., 2016). Finally, depletion of the cytoskeletal cross-
linker, plectin, leads to similar abnormalities in focal adhesions and
actin-dependent processes compared to vimentin depletion
(Abrahamsberg et al., 2005; Andra et al., 1998). The effects of
IFs and plectin on focal adhesions and the actin cytoskeleton have
been so far linked to integrin-driven activation of focal adhesion
kinase (FAK, also known as PTK2) and its downstream signaling
cascade (Gregor et al., 2014). However, the effects of IFs on the
stress fiber network and the underlying mechanisms have remained
obscure. In addition, the principles by which vimentin controls cell
adhesion, migration and invasion are incompletely understood.
Here, we report a vimentin-dependent downregulation of the
stress fiber network in osteosarcoma cells and in fibroblasts. We
show that depletion of vimentin results in an increased activation
and phosphorylation of GEF-H1. This leads to an increase in the
levels of active RhoA and consequent stress fiber assembly. Thus,
our work proposes a novel pathway by which vimentin IFs regulate
actin dynamics in cells.
RESULTS
Vimentin filaments inhibit the assembly of contractile stress
fibers
It is now well established that vimentin expression correlates with
increased cell motility and invasiveness, which in turn are
associated with actin dynamics. To this end, our recent work on
U2OS cells revealed that actin transverse arcs transport vimentin
filaments towards the cell center, whereas the vimentin IFs resist the
retrograde movements of these contractile actomyosin bundles (Jiu
et al., 2015). Interestingly, the vimentin-knockout U2OS cells also
display thicker stress fibers as detected by phalloidin staining, and
more intense tropomyosin 4.2 (for an explanation of tropomyosin
nomenclature, see Geeves et al., 2015) staining compared to control
cells (Fig. 1A). Tpm4.2 is a central stress fiber component that is
involved in myosin II recruitment to stress fibers (Tojkander et al.,
2011). To validate these findings, we performed western blot
analysis on vimentin-knockout and control cells. Consistent with
the immunofluorescence data, vimentin depletion resulted in a
significant increase in Tpm4.2 protein levels, while the actin levels
were only mildly increased upon vimentin depletion (Fig. 1C,D).
The interplay between vimentin and Tpm4.2 is not restricted to
U2OS cells, because immunofluorescence microscopy and western
blot experiments also demonstrated increased Tpm4.2 levels in
Fig. 1. Vimentin depletion induces stress fiber assembly. (A,B) The
intensities of Tpm4.2 and F-actin (as detected by fluorescent phalloidin) are
increased in vimentin-knockout U2OS cells (A) and knockdown HDF cells
generated using a vimentin siRNA pool (B). Panels on the left show
representative images of control (arrowheads) and vimentin-depleted cells
that were co-cultured on same plates. Panels on the right show the
quantifications of normalized relative Tpm4.2 fluorescent intensities in
control (A, 32 cells from nine images; B, 32 cells from nine images) and
vimentin-knockout or knockdown cells (A, 38 cells from nine images; B, 33
cells from nine images). Mean intensity values of control and knockout or
knockdown cells from each image were used for statistical analysis.
***P<0.001 (paired t-test). (C) Western blot analysis of actin and Tpm4.2
protein levels in control and vimentin-depleted U2OS (left panel) and HDF
(right panel) cells. The blots were also probed with vimentin antibody to
confirm that the vimentin-knockout U2OS cell culture is not contaminated by
wild-type U2OS cells and to verify efficiency of vimentin depletion in siRNA-
treated HDF cells, and with GADPH antibody to control equal sample
loading. Molecular masses in kilodaltons (kDa) are indicated in the blots.
(D) Quantification of the relative levels of actin (left panel) and Tpm4.2 (right
panel) normalized to internal control GAPDH from five western blots.
*P<0.05, ***P<0.001; N.S., not significant (paired t-test). (E) Vimentin-
knockout results in increased cell contractility detected by traction force
microscopy. Panels on the left show representative force maps of control
and vimentin-knockout cells grown on 25 kPa polyacrylamide dishes with
fluorescent nanobeads. The panel on the right shows the quantification of
traction forces (root mean square traction) in control cells (n=47) and
vimentin-knockout cells (n=47) from three independent experiments.
*P<0.05 (Mann–Whitney–Wilcoxon rank-sum test). The data are presented
as mean±s.e.m. Scale bars: 10 µm.
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RNA interference (RNAi)-induced vimentin-knockdown human
dermal fibroblasts (HDFs) (Fig. 1A–D).
Quantitative real-time RT-PCR (qRT-PCR) revealed no
significant differences in Tpm4.2 mRNA levels between control
and vimentin-knockout cells (Fig. S1A), indicating that vimentin
does not regulate Tpm4.2 at the transcriptional level. We thus
examined possible effects of vimentin on the stability of Tpm4.2
protein by treating U2OS cells with cycloheximide (CHX) to inhibit
protein translation. This experiment showed that Tpm4.2 was very
stable in CHX-treated vimentin-knockout cells during the 24 h
experimental period, whereas in control cells Tpm4.2 protein levels
were drastically diminished after a 6 h CHX-treatment (Fig. S1B).
Moreover, global disruption of actin stress fiber network upon
treatment with the myosin II inhibitor, blebbistatin, resulted in a
significant decrease in the Tpm4.2 protein levels (Fig. S1C),
indicating that Tpm4.2 protein is unstable and becomes degraded in
the absence of stress fibers. Thus, lack of vimentin leads to an
increased assembly and stability of stress fibers, and this
consequently results in a diminished turnover of the Tpm4.2
protein.
Because Tpm4.2 localizes specifically to myosin II-containing
transverse arcs and ventral stress fibers (Tojkander et al., 2011), we
hypothesized that loss of vimentin may also affect contractility of
stress fibers. Contractile force measurements performed using
traction force microscopy reveled that vimentin-knockout cells exert
∼25% greater traction forces compared to control cells (Fig. 1E). To
examine the activity of myosin II, control and vimentin-knockout
cells were stained with an antibody detecting phosphorylated
(Thr18/Ser19) myosin light chain (P-MLC; recognizing
phosphorylated myosin light chain 2). Lack of vimentin resulted
in ∼2-fold increases in P-MLC intensity and total P-MLC levels
when cells were grown on glass, or on a softer 33 kPa
polyacrylamide substrates (Fig. 2A,B). Conversely,
overexpression of vimentin reduced the intensities of Tpm4.2 and
P-MLC (Fig. S2C,D).
To examine whether the filamentous form of vimentin is
necessary for its effects on stress fibers, we performed knockout-
rescue experiments with wild-type vimentin and with the ‘unit
length filament’ (ULF) vimentin mutant Y117L, which preserves
vimentin interaction with other components of the cytoskeleton, but
cannot assemble into filaments (Meier et al., 2009). These
experiments revealed that whereas full-length GFP–vimentin can
rescue the stress fiber phenotype, the knockout cells expressing
‘non-polymerizable’ ULF–GFP displayed similar intensities of
Tpm4.2 and P-MLC compared to non-transfected vimentin-
knockout cells (Fig. 2C–F). Taken together, these data show that
intact vimentin IFs diminish stress fiber assembly, contractility,
myosin light chain phosphorylation and Tpm4.2 stability.
Vimentin depletion results in increased levels of active RhoA
RhoA regulates myosin light chain phosphorylation and activities of
several actin-binding proteins to promote stress fiber contractility
and assembly (Guilluy et al., 2011a,b; Lessey et al., 2012). We thus
hypothesized that levels of active RhoA may be regulated by
vimentin. By using G-LISA, a small GTPase activation assay, we
discovered that absence of vimentin significantly increased the level
of active GTP-bound, RhoA in U2OS cells (Fig. 3A). This effect
could be rescued by expression of full-length vimentin, but not by
the non-polymerizable ULF fragment, demonstrating that the
presence of filamentous vimentin is required for suppression of
RhoA activity (Fig. 3A). Based on immunostainings, western blot
analysis and qRT-PCR, we observed that neither the subcellular
localization nor the total protein levels and mRNA levels of RhoA
were affected by vimentin depletion (Fig. 3B,C; Fig. S3D). This
suggests that vimentin specifically controls the ratio of GTP- versus
GDP-loaded RhoA. Vimentin also exerted its effects on stress fibers
through RhoA activity; expression of dominant negative (DN)-
RhoA blocked the augmentation of Tpm4.2 and P-MLC levels in
both vimentin-knockout cells (Fig. 3D,E) and control U2OS cells
(Fig. S3A–C). It is, however, important to note that DN-RhoA can
compete for binding to Rho GDP dissociation inhibitors (GDIs) and
may thus have different effects in cells compared to RhoA
depletion. Taken together, these data demonstrate that vimentin
filaments inhibit stress fiber assembly by downregulating RhoA.
Vimentin regulates RhoA through GEF-H1
Because IFs associate with microtubules (Leduc and Etienne-
Manneville, 2015), we investigated by RNAi whether the
microtubule-associated RhoA exchange factor GEF-H1 (Ren
et al., 1998; Krendel et al., 2002) could mediate the cross-talk
between vimentin and RhoA signaling during stress fiber formation
and contractility. With appropriate siRNA oligonucleotide, we
Fig. 2. See next page for legend.
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succeeded in efficiently depleting GEF-H1 from U2OS cells
(Fig. 4A). Incubation of cells for 3 days with siRNAs against
GEF-H1 led to changes in cell morphology and to a dramatic
decrease in the number of stress fibers (data not shown), supporting
the known role of GEF-H1 in stress fiber assembly. Strikingly, by
using the G-LISA method, we found that silencing of GEF-H1
significantly diminished levels of active RhoA in both control and
vimentin-knockout cells (Fig. 4B). This result was further
confirmed with a different siRNA oligonucleotide against GEF-
H1 (Fig. S3F,G). Thus, GEF-H1 appears to be the predominant GEF
that activates RhoA in U2OS cells.
To elucidate the mechanism by which GEF-H1 is involved in
vimentin-mediated suppression of RhoA, we assessed the
interaction of endogenous vimentin and GEF-H1 by a co-
immunoprecipitation assay. This experiment provided evidence
that GEF-H1 either directly or indirectly interacts with vimentin
(Fig. 4C). Furthermore, in cells transfected with vimentin–mCherry,
and stained with anti-GEF-H1 and tubulin antibodies, vimentin
filaments often aligned with GEF-H1-containing microtubules
(Fig. 4D). We next examined whether vimentin regulates the
localization or dynamics of GEF-H1 in cells. Immunofluorescence
microscopy experiments demonstrated that GEF-H1 colocalized
similarly with microtubules in both control and vimentin-knockout
cells (Fig. 4E), whereas the dynamics of GEF-H1 were moderately
increased in vimentin-knockout cells compared to control cells.
Fluorescence recovery after photobleaching (FRAP) experiments on
cells expressing GFP–GEF-H1 revealed a highly dynamic
association of GEF-H1 with filamentous structures that are likely
to represent microtubules. However, the recoveries of both the
predominant dynamic population (halftime 1) and the smaller slow
Fig. 2. The filamentous form of vimentin is necessary for its effects on
stress fiber assembly. (A) The intensity of P-MLC is increased in vimentin-
knockout U2OS cells. The panel on the left shows representative images of
control (arrowheads) and vimentin-knockout cells that were co-cultured on
same plates. The panel on the right shows the quantification of normalized
relative P-MLC fluorescent intensities in control (35 cells from nine images) and
vimentin-knockout cells (37 cells from nine images). Mean intensity values of
control and knockout cells from each image were used for statistical analysis.
***P<0.001 (paired t-test). (B) Western blot analysis of P-MLC levels in control
and vimentin-knockout U2OS cells (left panel). The blots were also probedwith
vimentin antibody to confirm that the vimentin-knockout cell culture is not
contaminated by wild-type cells, and with GADPH antibody to verify equal
sample loading. Molecular masses in kilodaltons (kDa) are indicated in the
blots. The panel on the right shows the normalized relative levels of P-MLC
compared to the total MLC protein levels from three western blots. ***P<0.001
(paired t-test). (C,D) Full-length (FL) vimentin rescued the increase of
Tpm4.2 (C) and P-MLC (D) levels induced by vimentin depletion. Panels on the
left show representative images of vimentin-knockout cells expressing FL-
vimentin–GFP (arrowheads) and non-transfected vimentin-knockout cells.
Panels on the right show the quantifications of normalized relative Tpm4.2 (C,
33 control cells from eight images; 35 vimentin-knockout cells from eight
images) and P-MLC (D, 26 control cells from eight images; 28 vimentin-
knockout cells from eight images) fluorescence intensities. Mean intensity
values of control and vimentin overexpression cells from each image were
used for statistical analysis. **P<0.01 (paired t-test). (E,F) ‘Unit length form’
(ULF) vimentin is not able to rescue the increase of Tpm4.2 (E) and P-MLC (F)
levels induced by vimentin depletion. Panels on the left show representative
images of vimentin-knockout cells expressing ULF-vimentin–GFP
(arrowheads) and non-transfected vimentin-knockout cells. Panels on the right
show the quantifications of normalized relative Tpm4.2 (E, 27 control cells from
eight images; 32 knockout cells from eight images) and P-MLC (F, 29 control
cells from eight images; 28 knockout cells from eight images) fluorescent
intensities. Mean intensity values of control and ULF vimentin overexpression
cells from each image were used for statistical analysis. The data are
presented as mean±s.e.m. N.S., not significant. Scale bars: 10 µm.
Fig. 3. Vimentin depletion increases the levels of active RhoA.
(A) G-LISA analysis of the levels of active RhoA in wild-type, vimentin-
knockout, vimentin-knockout-rescue and vimentin overexpression U2OS
cells. Data are from five independent experiments and were normalized to
control cells. *P<0.05, ***P<0.001 (paired t-test). (B) Vimentin depletion
does not drastically affect the subcellular localization of RhoA.
Representative images show control (indicated by arrows) and vimentin-
knockout cells co-cultured on same plates. (C) Western blot analysis of
RhoA protein levels in control and vimentin-depleted U2OS cells. The blots
were also probed with vimentin antibody to confirm that the vimentin-
knockout cell culture is not contaminated by wild-type cells, and with
GAPDH antibody to verify equal sample loading. Molecular masses in
kilodaltons (kDa) are indicated in the blots. The panel on the right shows
the quantified relative levels of RhoA protein normalized to internal control
GAPDH from three western blots. (D,E) Expression of dominant negative
(DN) RhoA inhibits the increase of Tpm4.2 (D) and P-MLC (E) levels in
vimentin-knockout cells. Panels on the left show representative images of
DN-RhoA-expressing cells (indicated by arrows) in a vimentin-knockout
background. Panels on the right show the quantifications of normalized
relative Tpm4.2 (D, 31 control cells from ten images; 25 DN-RhoA
expressing cells from ten images) and P-MLC (E, 27 control cells from nine
images; 29 DN-RhoA-expressing cells from nine images) fluorescence
intensities. Mean intensity values of control and DN-RhoA overexpression
cells from each image were used for statistical analysis. ***P<0.001 (paired
t-test). The data are presented as mean±s.e.m. N.S., not significant. Scale
bars: 10 µm.
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population (halftime 2) of GEF-H1 were more rapid in vimentin-
knockout cells (halftimes 1 and 2 of ∼1.5 s and ∼28 s, respectively)
compared to control cells (halftimes 1 and 2 of ∼2.4 s and ∼44 s,
respectively), while the sizes of mobile fractions were very similar
in both cases (95% and 94%, respectively) (Fig. 4F,G).
Vimentin depletion results in increased activity and
phosphorylation of GEF-H1
We next examined whether GEF-H1 activity is affected by vimentin.
By using an activity assay that is based on co-sedimentation of GEFs
with the GST–RhoA-G17A nucleotide-free mutant (Garcia-Mata
et al., 2006), we revealed that the level of active GEF-H1 was ∼3-
fold higher in vimentin-knockout cells compared to control cells
(Fig. 5A). To elucidate the underlying mechanism, we examined the
effects of vimentin depletion on phosphorylation of GEF-H1 on
Ser886 (which is the only GEF-H1 phosphorylation site for which a
commercial antibody is available). The specificity of the antibody
was confirmed by western blot in cells expressing phosphorylation-
deficient (S886A) GEF-H1 mutant (Fig. S4C). Strikingly, our
results showed that GEF-H1 phosphorylation on Ser886 was
strongly elevated in vimentin-knockout and knockdown versus
control U2OS cells (Fig. 5B, Fig. S4B), whereas GEF-H1 protein
and mRNA levels were not significantly altered (Fig. S3E). This
mechanism is not specific to the cell type, because knockdown of
vimentin from HDF cells resulted in a similar increase in GEF-H1
phosphorylation on Ser886 (Fig. S4A,B).
GEF-H1 phosphorylation on Ser886 was previously shown to
induce 14-3-3 binding to the exchange factor, and relocation of 14-
3-3 proteins to microtubules (Zenke et al., 2004). To determine
whether GEF-H1 phosphorylation on Ser886 regulates the
enzymatic activity of GEF-H1 in the context of actin stress fiber
assembly, we examined the effects of wild-type GEF-H1 as well
as the phosphomimetic (S886D) and phosphorylation-deficient
(S886A) GEF-H1 mutants on RhoA activity in U2OS cells by using
the G-LISA assay. Because transfection efficiency of these cells is
quite high (>80%) for all GEF-H1 constructs, it was possible to
examine the effects of these constructs on RhoA-activity using
transiently transfected cells. Whereas wild-type GEF-H1-
expressing cells displayed only a relatively small increase in the
levels of active RhoA compared to control cells expressing GFP,
overexpression of the phosphomimetic S886D mutant resulted in an
almost 2-fold increase in the levels of active RhoA. The
phosphorylation-deficient S886A mutant did not increase active
RhoA over control levels (Fig. 5C). Furthermore, expression of the
phosphomimetic S886D GEF-H1 resulted in increases in Tpm4.2
and P-MLC levels, whereas expression of the S886A GEF-H1
mutant had no detectable effects on Tpm4.2 or P-MLC levels
(Fig. 5D,E). These data show that GEF-H1 phosphorylation on
Ser886 increases its guanine nucleotide exchange activity towards
RhoA, and consequently affects stress fiber assembly and
contractility.
Fig. 4. GEF-H1 is critical for vimentin-mediated suppression of RhoA
activity. (A) Western blot demonstrating that GEF-H1 was efficiently silenced
by siRNA (siGEF-H1) in both control and vimentin-knockout cells. The blot was
also probed with GADPH antibody to verify equal sample loading. (B) G-LISA
analysis of the levels of active RhoA in GEF-H1-silenced control and vimentin-
knockout cells. The data are from five independent experiments and were
normalized to results in control cells. ***P<0.001 (paired t-test). (C) Co-
immunoprecipitation (IP) of GEF-H1 with vimentin from U2OS cell extracts.
Whole-cell extracts were used for immunoprecipitation with an anti-GEF-H1
antibody, then probed with an anti-vimentin antibody. IgG is shown as a
negative control. Molecular masses in kilodaltons (kDa) are indicated.
(D) Image of a cell transfected with vimentin–mCherry, and stained with
GEF-H1 and tubulin antibodies. Magnified regions from the area indicated by a
yellow box demonstrate that vimentin filaments often colocalize with GEF-H1-
containing microtubules. (E) Endogenous GEF-H1 displayed similar
colocalization with microtubules in both control and vimentin-knockout cells.
(F) Representative examples of GFP–GEF-H1 dynamics in control and
vimentin-knockout cells as examined by FRAP. (G) Averaged recovery curves
of the raw data are shown on the left (control n=15; vimentin knockout, n=17).
The insert shows the recovery curves during the first 5 s following
photobleaching. The averaged curves were fitted with double exponential
equation, and mobile fractions and halftime values were calculated from the
fitted data. The data are presented as mean±s.e.m. N.S., not significant. Scale
bars: 10 µm.
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Earlier studies provided evidence that IFs can affect stress fiber
formation through plectin-mediated interactions with focal
adhesions. The lack of vimentin or plectin were shown to lead to
attenuation of the activities of FAK and its downstream kinases and
upregulation of a compensatory feedback loop acting on RhoA
(Gregor et al., 2014). FAK and its downstream kinases were, in
other studies, demonstrated to regulate RhoA by activating its
negative regulators RhoA GTPase-activating proteins (GAPs)
(Aikawa et al., 2002; Schober et al., 2007). Based on western blot
analysis, we found that neither the total protein levels nor the levels
of active FAK and MEK1 and MEK2 (MEK1/2; also known
MAP2K1 and MAP2K2, respectively) were drastically affected by
vimentin depletion (Fig. S4D). To examine whether activation of
FAK has effects on GEF-H1 phosphorylation on Ser886, or on
vimentin-mediated attenuation of stress fiber assembly and
contractility in U2OS cells, we used inhibitors of FAK (FAK-14)
and its downstream kinases MEK1/2 (U0126), which diminished
the levels of active phosphorylated kinases (Fig. S4E). While FAK-
14 and U1026 slightly reduced the basal levels of GEF-H1
phosphorylation, neither of them inhibited the GEF-H1
phosphorylation on Ser886 induced by vimentin depletion
(Fig. 6A,B). Furthermore, these compounds did not rescue the
increased Tpm4.2 and P-MLC levels of vimentin-knockout cells
(Fig. 6C,D). Taken together, we demonstrate that vimentin controls
RhoA activity and stress fiber assembly through a novel GEF-H1-
dependent pathway.
DISCUSSION
Recent studies have demonstrated that the three cytoskeletal
systems, actin filaments, microtubules and IFs, interact with each
other, and exhibit interconnected functions in cell migration,
morphogenesis and mechano-responsiveness (Huber et al., 2015).
However, the mechanisms by which IFs affect the assembly and
contractility of actin stress fibers have remained obscure. Here, we
reveal that, first, vimentin filaments negatively regulate stress fiber
assembly and contractility. Consequently, vimentin depletion results
in accumulation of a central stress fiber component Tpm4.2 and
increased myosin light chain phosphorylation. Second, vimentin
Fig. 5. Vimentin depletion results in increased activity and
phosphorylation of GEF-H1. (A) Active GEF-H1 was co-sedimented with
GST–RhoA-G17A, and detected by western blotting using an anti-GEF-H1
antibody. The lower panel shows the quantification of normalized relative levels
of GEF-H1 co-sedimenting with GST–RhoA-G17A compared to total GEF-H1
levels in cell lysates from five western blots. ***P<0.001 (paired t-test).
(B)Western blot analysis of GEF-H1 phosphorylated on Ser886 and total GEF-
H1 levels in control and vimentin-knockout cells. The blots were also probed
with vimentin antibody to confirm that the vimentin-knockout cell culture is not
contaminated by wild-type cells, and with GADPH antibody to verify equal
sample loading. The lower panel shows the quantification of normalized
relative levels of P-GEF-H1 (Ser886) compared to total GEF-H1 levels from
five western blots. ***P<0.001 (paired t-test). Molecular masses in kilodaltons
(kDa) are indicated. (C) G-LISA analysis of the levels of active RhoA in wild-
type, phospho-mimic (S886D) and phospho-deficient (S886A) GEF-H1-
expressing cells. The data are from five independent experiments and were
normalized to control cells. **P<0.01 (paired t-test). (D) Tpm4.2 levels are
increased in cells expressing the phospho-mimic (S886D) GEF-H1mutant, but
not in cells expressing the phospho-deficient (S886A) mutant. Upper panels
show representative images of control cells and cells expressing wild-type or
mutant GEF-H1 (arrowheads). The lower panel shows the quantification of
normalized relative Tpm4.2 fluorescence intensities (wild-type GEF-H1: 32
control cells from nine images and 31 transfected cells from nine images; GEF-
H1-S886D: 32 control cells from ten images and 35 transfected cells from total
ten images; GEF-H1-S886A: 32 control cells from nine images and 38
transfected cells from nine images). Mean intensity values of control and GEF-
H1 overexpression cells from each image were used for statistical analysis.
*P<0.05; ***P<0.001 (paired t-test). (E) P-MLC levels are increased in cells
expressing the phospho-mimic (S886D) GEF-H1 mutant, but not in cells
expressing the phospho-deficient (S886A) mutant. Upper panels show
representative images of control cells and cells expressing wild-type or mutant
GEF-H1 (arrowheads). The lower panel shows the quantification of normalized
relative P-MLC fluorescence intensities (wild-type GEF-H1: 35 control cells
from nine images and 29 transfected cells from nine images; GEF-H1-S886D:
35 control cells from ten images and 33 transfected cells from ten images;
GEF-H1-S886A: 35 control cells from nine images and 28 transfected cells
from nine images). Mean intensity values of control and GEF-H1
overexpression cells from each image were used for statistical analysis.
*P<0.05, ***P<0.001 (paired t-test). The data are presented as mean±s.e.m.
N.S., not significant. Scale bars: 10 µm.
897
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 892-902 doi:10.1242/jcs.196881
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
filaments inhibit stress fiber assembly and contractility through
down-regulating GEF-H1 and RhoA. Finally, vimentin controls
GEF-H1 activity through modulating its phosphorylation on Ser886.
Taken together, these data unravel new mechanisms by which
vimentin IFs regulate the assembly and contractility of actomyosin
bundles. Our results on the interplay between vimentin IFs and stress
fibers may also explain why elevated expression levels of vimentin
correlate with increased invasion and metastasis potential of cancer
cells (e.g. Eckes et al., 1998; Mendez et al., 2010).
We show that vimentin depletion has comparable effects on stress
fiber assembly, Tpm4.2 levels and GEF-H1 phosphorylation in both
U2OS cells and dermal fibroblasts, indicating that the pathway by
which vimentin regulates actin stress fibers is conserved in different
mesenchymal cell types. However, whether the pathway identified
here is also conserved in other animal cell types, including epithelial
and endothelial cells, remains to be examined. Furthermore, our data
provide evidence that Tpm4.2 is unstable in the absence of stress
fibers, and thus the elevated Tpm4.2 levels in vimentin-depleted
cells are due to increased assembly of stress fibers instead of more
direct effects of vimentin, for example on Tpm4.2 transcription.
Importantly, the vimentin–GEF-H1–RhoA–stress-fiber pathway
identified here is different from the FAK-dependent compensatory
feedback loop that was recently proposed to operate in the absence
of vimentin and plectin (Gregor et al., 2014). This is because
inhibitors against FAK and its downstream kinases could not rescue
the effects of vimentin depletion on GEF-H1 phosphorylation,
stress fiber assembly and contractility, although they resulted in a
small decrease in GEF-H1 phosphorylation levels in control cells.
Furthermore, earlier studies proposed that vimentin and plectin
depletions regulate RhoA by attenuating the activity of FAK, which
in turn leads to downregulation of both ARHGAP35 and
ARHGAP5 (also known as p190RhoGAP) (Schober et al., 2007),
rather than upregulation of GEF-H1 as shown by our results.
Finally, plectin-null cells were shown to exert lower tractions to their
environment compared to control cells (Schober et al., 2007; Gregor
et al., 2014), whereas our study demonstrates that vimentin
depletion increases contractility. Thus, inactivation of plectin and
vimentin manifest differently on stress fibers and mechanical
regulation of the cell. We do not rule out other mechanisms by
which vimentin may control stress fiber assembly, for example,
through regulating Rac1 activity via its GEF VAV2 at focal
adhesions (Havel et al., 2015). Neither do we rule out other
confounding factors including cell density and soft substrates that
independently impact vimentin-dependent cell spreading and
contractility (Mendez et al., 2014). In this regard, we emphasize
that our findings were concordant between cells on glass and 33 kPa
substrates.
How does vimentin control the GEF-H1 activity? First, we
showed that GEF-H1 localization to microtubules is not drastically
altered upon vimentin depletion. Next, by focusing on the GEF-H1
phosphorylation in control and vimentin-knockout cells, we showed
that GEF-H1 phosphorylation on Ser886 was significantly
increased in vimentin-deficient cells. Although previous studies
Fig. 6. GEF-H1 suppression by vimentin does not involve FAK and its
downstream kinases. (A) Western blot analysis of GEF-H1 phosphorylated
on Ser886 and total GEF-H1 levels in control and vimentin-depleted U2OS
cells incubated in the presence or absence of FAK inhibitor FAK-14 (left panel)
or MEK inhibitor U0126 (right panel). The blots were also probed with GADPH
antibodies to verify equal sample loading. Molecular masses in kilodaltons
(kDa) are indicated. (B) Quantification of normalized relative levels of P-GEF-
H1 (Ser886) compared to total GEF-H1 levels from five western blots for each
condition. *P<0.05, **P<0.01, ***P<0.001 (paired t-test).
(C,D) Immunostainings demonstrating that neither FAK-14 nor U0126
compounds could suppress the increased Tpm4.2 and P-MLC levels that were
induced by depletion of vimentin. Wild-type cells in each panel are indicated
with arrowheads. Panels on the right show the quantifications of normalized
relative Tpm4.2 (C, FAK14: 28 control cells from six images and 29 vimentin-
knockout cells from six images; U0126: 31 control cells from seven images and
28 vimentin-knockout cells from seven images) and P-MLC (D, FAK14: 33
control cells from seven images and 34 vimentin-knockout cells from seven
images; U0126: 28 control cells from six images and 27 vimentin-knockout
cells from six images) fluorescence intensities. Mean intensity values of control
and vimentin-knockout cells from each imagewere used for statistical analysis.
***P<0.001 (paired t-test). The data are presented as mean±s.e.m. N.S., not
significant. Scale bars: 10 µm.
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demonstrated that GEF-H1 phosphorylation simultaneously on both
Ser886 and Ser959 or only on Ser959 inhibit its activity (Birkenfeld
et al., 2007; Yamahashi et al., 2011; Von Thun et al., 2013), our
experiments using a phosphomimetic mutant protein provided
evidence that GEF-H1 phosphorylation on Ser886 in U2OS cells
results in its activation. Various kinases, including PAKs, Aurora A,
Cdk1 and PAR1b (also known as MARK2) can inactivate GEF-H1
by phosphorylating inhibitory sites (Birkenfeld et al., 2007; Callow
et al., 2005; Yamahashi et al., 2011), whereas extracellular signal-
regulated kinase 1 and 2 (ERK1/2, also known as MAPK3 and
MAPK1, respectively) phosphorylates GEF-H1 at the activating site
Thr678 (Fujishiro et al., 2008; Guilluy et al., 2011a,b). Thus, as with
many GEFs, regulation of GEF-H1 is a complex process, involving
phosphorylations on several different sites that affect interactions of
the protein with other kinases and interaction partners. These
interaction partners may further activate GEF-H1 as demonstrated
by a recent study in which the bacterial translocation type III
secretion effector VopO was shown to bind GEF-H1 and
consequently active the RhoA–ROCK pathway and actin stress
fiber formation (Hiyoshi et al., 2015).
The mechanism by which vimentin downregulates
phosphorylation of GEF-H1 on Ser886 can either depend on the
availability of GEF-H1 for phosphorylation or from activation of a
specific kinase in the absence of vimentin. Previous studies
demonstrated that PAK1 phosphorylates GEF-H1 on Ser886
(Zenke et al., 2004). PAK1 silencing also attenuates vimentin
phosphorylation on Ser56, and vimentin phosphorylation on Ser56
inversely regulates PAK1 activity in smooth muscle cells stimulated
by 5-hydroxytryptamine (5-HT; serotonin) (Li et al., 2006).
However, whether vimentin can regulate PAK1 and its
downstream signaling in non-muscle cells has not been reported.
Our western blot analysis indicated that neither PAK1 protein levels
nor its activity (as detected by PAK1 phosphorylation on Thr423)
were increased by vimentin depletion in U2OS cells. In addition,
PAK1 inhibitor (IPA-3) did not affect the levels of Ser886
phosphorylated GEF-H1 in vimentin-knockout cells (Fig. S4F),
indicating that PAK1 is not involved and that the signaling cascade
in vimentin-mediated GEF-H1 regulation is more complex and is
likely to involve other kinases. Moreover, absence of vimentin
resulted in a small, but reproducible, increase in the GEF-H1
dynamics (Fig. 4F,G). Therefore, it is also possible that vimentin
depletion does not activate specific kinases, but instead makes GEF-
H1 more available for these kinases due to its increased dynamics.
Vimentin is a well-characterized biomarker of epithelial–
mesenchymal transitions (EMTs). Several studies on multiple
tumor types demonstrated that vimentin is specifically expressed in
invasive cell lines, but not in stationary cancer cells (Singh et al.,
2003; Hu et al., 2004; Wei et al., 2008). Furthermore, absence of
vimentin was shown to lead to decreased cell migration speed and
directionality (Eckes et al., 1998, 2000). Our work demonstrating
effects of vimentin on GEF-H1 and RhoA activity, and downstream
stress fiber assembly and contractility, may provide an explanation
for these observations. Because extensive stress fibers enhance
adhesion and inhibit cell motility, we speculate that upregulation of
vimentin stimulates cell migration at least partially through
inhibiting stress fiber assembly and contractility. In this context, it
is important to note that altered GEF-H1 activity and expression
levels have been linked to cancer progression (Cheng et al., 2012;
Cullis et al., 2014; Biondini et al., 2015). Thus, in the future it will
be interesting to examine how the vimentin–GEF-H1–RhoA
pathway identified in our study contributes to the role of vimentin
in cell migration and invasion in vivo.
MATERIALS AND METHODS
Cell culture and transfections
Human osteosarcoma (U2OS) cells and human dermal fibroblasts (HDFs)
were maintained as described in Jiu et al. (2015). Vimentin-knockout U2OS
cells were generated using CRISPR/Cas9 methods (Jiu et al., 2015).
Transient transfections were performed with FuGENE HD transfection
reagent (Promega) according to the manufacturer’s instructions. Cells were
subsequently incubated for 24 h and either fixed with 4% PFA (for GEF-H1
antibody staining, cells were fixed with methanol) or used for FRAP by
detaching the cells with trypsin-EDTA and plating them on fibronectin-
coated (10 μg/ml) glass-bottomed dishes (MatTek). For siRNA silencing,
pre-annealed 3′ oligonucleotide duplexes were transfected into cells on
35 mm plates by using Lipofectamine RNAiMAX transfection reagent
(Invitrogen) according to the manufacturer’s instructions. Cells were
incubated for 72 h for efficient depletion of the target proteins. For the
cyclohexamide experiment, both wild-type and vimentin-knockout cells
were treated with 20 μg/ml cyclohexamide (Sigma) in complete Dulbecco’s
modified Eagle’s medium (DMEM) and harvested at corresponding time
points. For the drug experiments, cells were treated with 10 µM blebbistatin
(Sigma) for 30 min, 2 µM FAK inhibitor FAK14 (Tocris) for 30 min, 25 µM
MEK inhibitor U0126 (Tocris) for 30 min, or 30 µM PAK1 inhibitor IPA-3
(Tocris) for 1 h before they were harvested for western blot analysis or fixed
for immunofluorescence.
Plasmids and siRNA oligonucleotides
Cloning strategy for constructs expressing GFP-tagged full-length vimentin
or ‘unit length filament’ (ULF) and vimentin–mCherry are described in
Yoon et al. (1998) and Eriksson et al. (2004). Dominant negative pRK5myc
RhoA N19 (deposited by Alan Hall, Addgene plasmids #15900 and
#15901). Wild-type GFP-GEF-H1, phosphomimetic S886D GFP-GEF-H1
and phosphorylation-deficient S886A GFP-GEF-H1 were kind gifts from
Katalin Szaszi (St. Michael’s Hospital, Toronto, Canada). pGEX-4T1-
RhoA G17A was a gift from Rafael Garcia-Mata (Addgene plasmid #
69357). The ON-TARGET siRNA-SMART pool L-003551-00-0005 was
used for vimentin knockdown in HDF cells and the siRNA target sequence
5′-UCACGAUGACCUUGAAUAA-3′ was used for vimentin knockdown
in U2OS and HDF cells (Dharmacon). The siRNA target sequences
5′-GACUCAGACUCUAGCCAGA-3′ and 5′-CAGAUGUGUAAGACC-
UACU-3′ were used for GEF-H1 knockdown (Bioneer). AllStars Negative
Control siRNA (Qiagen) was used as a control siRNA.
Western blotting
Cells werewashed three times with cold PBS, scraped, and lysed in Laemmli
sample buffer (LSB) with 0.3 mM PMSF and protease and phosphatase
inhibitor cocktail (Pierce). Protein concentrations were measured by using
Bradford reagent (Sigma-Aldrich). 5% milk was used in blocking and
washes were done by using TBST buffer (Tris-buffered saline, 0.1% Tween
20). Antibodies were used with the following dilutions in 5% BSA:
vimentin rabbit polyclonal D21H3 antibody (dilution 1:1000; #5741, Cell
Signaling); Tpm4.2 mouse monoclonal LC24 antibody (dilution 1:500; a
kind gift from Peter W. Gunning, UNSWAustralia); phospho-myosin light
chain 2 (Thr18/Ser19) rabbit polyclonal antibody (dilution 1:500; #3674,
Cell Signaling); myosin light chain mouse monoclonal antibody (dilution
1:1000; #M4401, Sigma); GEF-H1 rabbit monoclonal 55B6 antibody
(dilution 1:1000; #4076, Cell Signaling); phospho-GEF-H1 (Ser886) rabbit
monoclonal E1L6D antibody (dilution 1:1000; #14143, Cell Signaling);
actin mouse polyclonal AC40 antibody (dilution 1:1000; #A4700, Sigma);
RhoA rabbit polyclonal antibody (dilution 1:1000; #SAB2102002, Sigma);
FAK rabbit polyclonal antibody (dilution 1:1000; #3285, Cell Signaling);
phospho-FAK (Tyr397) rabbit polyclonal antibody (dilution 1:1000; #3283,
Cell Signaling); MEK1/2 mouse polyclonal L38C12 antibody (dilution
1:1000; #4694, Cell Signaling); phospho-MEK1/2 (Ser217/221) rabbit
polyclonal 41G9 antibody (dilution 1:1000; #9154, Cell Signaling); PAK1
rabbit polyclonal antibody (dilution 1:1000; #2602, Cell Signaling);
phospho-PAK1 (Thr423) rabbit polyclonal antibody (dilution 1:1000;
#2601, Cell Signaling); GAPDH mouse polyclonal antibody (dilution
1:1000; G8795, Sigma). Horseradish peroxidase (HRP)-linked secondary
antibodies were used and chemiluminescence was measured after applying
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western blotting ECL spray (Advansta). The ImageJ program was applied to
measure the band intensities of blots. In the quantifications, we calculated
the intensity ratios of phosphorylated protein to protein of interest versus
total protein to the internal control GAPDH. The values of control cells were
set to 1 in each experiment, and the differences between the control and the
knockout, knockdown or drug treatment cells in corresponding blots were
calculated. The statistical differences between the two groups were assessed
using the paired t-test. P<0.05 was considered significant.
Immunofluorescence microscopy
Immunofluorescence experiments were performed as previously described
(Jiu et al., 2015). Briefly, the cells were fixed with 4% PFA, washed three
times with 0.2% BSA in Dulbecco's phosphate buffered saline and
permeabilized with 0.1% Triton X-100 in PBS. The following primary
antibodies were used: vimentin rabbit polyclonal D21H3 antibody (dilution
1:100; #5741, Cell Signaling) when cells were co-stained with Tpm4.2
antibody; vimentin mouse polyclonal V9 antibody (dilution 1:100; #V6630,
Sigma) when cells were co-stained with P-MLC antibody; Tpm4.2 mouse
monoclonal LC24 antibody (dilution 1:150; a kind gift from Peter W.
Gunning, UNSW Australia); phospho-myosin light chain 2 (Thr18/Ser19)
rabbit polyclonal antibody (dilution 1:100; #3674, Cell Signaling); RhoA
rabbit polyclonal antibody (dilution 1:100; #SAB2102002, Sigma); GEF-
H1 rabbit polyclonal antibody (dilution 1:50; #ab155785, Abcam); tubulin
mouse monoclonal antibody (dilution 1:100; #4026, Sigma). Secondary
antibodies were conjugated to Alexa Fluor 488, 568 or 647 (Invitrogen). F-
actin was visualized with Alexa Fluor 488-, 568- or 647 conjugated to
phalloidin (dilution 1:200; Invitrogen). Cells were imaged either with a
wide-field fluorescence microscope (Leica DM6000) with a HCXPL APO
63×1.40-0.60 NA oil objective or by Leica TCS SP5 laser scanning confocal
microscope with a 63×1.3 NA glycerol objective. Because the GEF-H1
antibody from Cell Signaling used for all western blot experiments does not
work in immunofluorescence, we used GEF-H1 antibody from Abcam for
immunofluorescence experiments where cells were fixed by methanol for
5 min at −20°C. For comparing Tpm4.2, P-MLC and RhoA levels, the
control and vimentin-knockout or knockdown cells were mixed and
distinguished from each other by vimentin antibody staining. Please note
that vimentin, Tpm4.2, P-MLC, RhoA and GEF-H1 levels were constant
between different control cells (data not shown). In the quantifications, we
first measured the intensities (corresponding to expression levels) of a protein
of interest in all control cells from individual immunofluorescence images
and set the mean value to 1. Subsequently, the values from all knockout or
knockdown cells from the same image were compared to the mean value
obtained from the control cells. The mean intensity values of knockout or
knockdown cells (normalized to the values obtained from control cells) from
individual immunofluorescence images were used for the statistical analysis.
s.e.m. represents the variation of mean intensities between individual
immunofluorescence images. The statistical differences between two groups
was assessed by using a paired t-test. P<0.05 was considered significant.
FRAP
To analyze the kinetics of GEF-H1, wild-type and vimentin-knockout cells
were transfected with GFP–GEF-H1 and incubated for 24 h. Confocal
images were acquired with a 3I Marianas imaging system (3I Intelligent
Imaging Innovations), consisting of an inverted spinning disk confocal
microscope Zeiss Axio Observer Z1 (Zeiss), a Yokogawa CSU-X1 M1
confocal scanner and 63×1.2 NA WC-Apochromat Corr WD=0.28 M27
objective (Zeiss). A heated sample environment (+37°C) and CO2 control
were used. SlideBook 6.0 software (3I Intelligent Imaging Innovations) was
used for the image acquirement. Five pre-bleach images were acquired
followed by bleaching scans with 100% intensity laser lines over the region
of interest. Recovery of fluorescence was monitored 50 times every 200 ms
and 300 times every 1 s. The intensity of the bleached area was normalized
to a neighboring non-bleached area. Mean scatter plots were calculated from
different FRAP experiments and the data were fitted with SigmaPlot 11.0
to f=a×(1×exp(×b×x))+c×(1−exp(−d×x)) double exponential equations.
Recovery halftimes were obtained for each recovery curve and the means
and standard deviations were calculated.
Quantitative real-time RT-PCR
The total RNA was extracted from U2OS cells using RNeasy mini
kits (Qiagen). cDNAwas obtained by reverse-transcribing the same amount
of total RNA using High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems). The complementary DNA products were
amplified using sequence-specific primers for Tpm4.2 (forward, 5′-AGA-
AAGCGCTGAGGACAAG-3′; reverse, 5′-TTGGTGAGCCCTGTCCAA-
CT-3′), RhoA (forward, 5′-CATCCGCTCCTTTGATGATCTT-3′; reverse,
5′-TGCTCGGGTCATGTTCAAGT-3′), GEF-H1 (forward, 5′- AGCCT-
GTGGAAAGACATGCTT-3′; reverse, 5′-TCAAACACTGTGGGCACA-
TAC-3′) and GAPDH (forward, 5′-TCGGTGTGAACGGATTTG-3′;
reverse, 5′-GGTCTCGCTCCTGGAAGA-3′). The transcript levels of the
genes of interest were measured by qRT-PCR using the SYBR Green PCR
mix (Applied Biosystems) in an Applied Biosystems 7300 detection system
(Bio-Rad). The data were normalized to the expression levels of the cellular
housekeeping gene GAPDH.
RhoA activity assay
RhoA activity was measured by using a RhoA G-LISA absorbance-based
biochemical assay kit (Cytoskeleton) according to the manufacturer’s
instructions. In brief, cells were lysed, aliquoted and snap frozen in liquid
nitrogen. After rapid thawing, binding buffer was added to the cell lysate,
which was subsequently incubated on a RhoA-GTP affinity plate coated
with RhoA-GTP-binding protein in each well. The plate was placed on an
orbital plate shaker at 400 rpm for 30 min at 4°C. After washes, primary anti-
RhoA antibodies (1:250) and secondary HRP-linked antibodies (1:62.5)
were sequentially added to the wells followed by an incubation on an orbital
shaker at 400 rpm for 45 min at room temperature. Thereafter, the signal was
developed with HRP-detection reagents. The absorbance was measured by
means of a plate reader spectrophotometer Enspire (PerkinElmer). In the
quantifications, the absorbance values of control cells were set to 1 in each
experiment, and the differences between the control and the knockout,
knockdown or transfection cells in corresponding experiments were
calculated. The statistical differences between the two groups were
assessed using the paired t-test. P<0.05 was considered significant.
GEF activity assay
The activity of GEF-H1 was assayed by using GST–RhoA-G17A
nucleotide-free mutants as described previously (Garcia-Mata et al., 2006).
Cells were lysed in lysis buffer (150 mM NaCl, 20 mM HEPES, pH 7.4,
5 mM MgCl2, 1% Triton X-100, 1 mM DTT, 1 mM PMSF, 10 μg/ml
aprotinin and leupeptin), incubated with 50 µg/ml glutathione–Sepharose-
bound GST-RhoA G17A for 60 min at 4°C, and washed in the lysis buffer.
Samples were subsequently analyzed by western blotting with the GEF-H1
antibody.
Co-immunoprecipitation
Cells were harvested and lysed in NP-40 lysis buffer (50 mM Tris-HCl pH
7.4, 50 mM NaCl, 0.1% Triton X-100, 1% NP-40) plus 1× Roche complete
protease inhibitors (Roche). Total cell lysate was used for
immunoprecipitation. Primary GEF-H1 antibody (10 μg) was incubated
with 50 μl (1.5 mg) of Dynabeads (Life Technologies) for 2 h at 4°C while
under rotating. Cell lysate was then mixed with Dynabeads–antibody
complexes and incubated overnight at 4°C while under rotating. After three
20 min washes with NP-40 lysis buffer, the protein–antibody complexes
were eluted from the beads in 20 µl NuPAGE LDS sample buffer. Samples
were subsequently analyzed by western blotting with the vimentin antibody.
Polyacrylamide substrate preparation
Polyacrylamide (PA) gels were constructed and coated with fibronectin as
described previously (Damljanovic et al., 2005). Briefly, coverslips were
treated with 3-aminoplopyltrimethoxy silane, dried and soaked in 0.5%
glutaraldehyde. In order to prepare gels of 33 kPa stiffness, acrylamide
(40%, Bio-Rad), Bis (2%, Bio-Rad), HEPES (1 M) and distilled water were
mixed in concentrations of 5% acrylamide with 0.12% Bis. Gels were
crosslinked using ammonium persulfate (10%) and TEMED. A 15 μl of the
mixture was allowed to polymerize between the activated coverslip and a
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normal coverslip. PA gels needed for the experiments were constructed
concurrently and used immediately. PA gels were activated for protein
cross-linking with sulfo-SANPAH (Pierce Biotechnology) under a UV lamp
and coated with fibronectin (10 µg/ml) at 4°C overnight. Prior to
experiments, the gels were covered with PBS in UV lamp for 30 min to
sterilize and then equilibrated with DMEM at 4°C, 5% CO2, for 45 min.
Traction force microscopy
Both control and vimentin-knockout cellswere cultured for 3–8 h on custom-
made 35 mm dishes (Matrigen) with fibronectin-coated polyacrylamide gel
(elastic modulus 25 kPa). 200 nm YG fluorescent (505/515) microspheres
were immobilized to the surface of the gel as described previously
(Marinkovic et al., 2012). Using an inverted fluorescence microscope (3I
Marianas), images of the cells and of the fluorescent microspheres directly
underneath the cells were acquired during the experiments and after cell
detachment with trypsin. By comparing the reference image with the
experimental image, we computed the cell-exerted displacement field. From
the displacement fields, and manual traces of the cell contours, together with
knowledge of substrate stiffness, we computed the traction force fields using
the approach of constrained Fourier-transform traction cytometry (Butler
et al., 2002). From the traction fields, we calculated the root mean squared
values (RMS) of tractions. Because tractions vary log-normally (Krishnan
et al., 2009), statistical differences in RMS traction between the control and
vimentin-knockout groups were assessed by using the Mann–Whitney–
Wilcoxon rank-sum (MWW) test. P<0.05 was considered significant.
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